ConductScience.org, home

Paper42441024

YAP1 depletion enhances TAZ and its complexation with TEAD4 and AP-1 heterodimer C-JUN/FOSB in gastric cancer progression and metastasis.

Wu J and 24 others. Cancer Heterog Plast, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. YAP1 depletion enhances TAZ and its complexation with TEAD4 and AP-1 heterodimer C-JUN/FOSB in gastric cancer progression and metastasis. Papers, record 42441024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42441024

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
YAP1 depletion enhances TAZ and its complexation with TEAD4 and AP-1 heterodimer C-JUN/FOSB in gastric cancer progression and metastasis.
PubMed
Journal
Cancer Heterog Plast
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-23
PubMed

Authors25

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu JJingjing
2Athavale DDipti
3Balch CCurt
4Zhao JJunsong
5Zou GGengyi
6Fan YYibo
7Zhang YYanting
8Zhao JJoseph
9Ghelfi MMikel
10Pompetti AAnthony
11Calendo GGennaro
12Scott AAiling
13Shao SShan
14Yao XXiaodan
15Pizzi MPMelissa Pool
16Vellano CChristopher
17Khazak VVladimir
18Zhang SSheng
19Yap TATimothy A
20Dhar SSShilpa S

Source PubMed

See all 25 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA230323NCI NIH HHSUnited StatesR01CA230323PubMedNIH RePORTER
R01 CA269685NCI NIH HHSUnited StatesR01CA269685PubMedNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of41292957YAP1 Depletion Enhances TAZ and its Complexation with TEAD4 and AP-1 Heterodimer C-JUN/FOSB to Promote Gastric Cancer Progression and Metastases.https://conductscience.org/library/papers/41292957

Source PubMed

Download CSV of comments and corrections

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137277530An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance.Nat Cancer2023https://conductscience.org/library/papers/37277530PubMed
232175692Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.Mol Oncol2020https://conductscience.org/library/papers/32175692PubMed
323536563Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma.Cancer Res2013https://conductscience.org/library/papers/23536563PubMed
428035666Roles and regulations of Hippo signaling during preimplantation mouse development.Dev Growth Differ2017https://conductscience.org/library/papers/28035666PubMed
532345613YAP1 mediates gastric adenocarcinoma peritoneal metastases that are attenuated by YAP1 inhibition.Gut2021https://conductscience.org/library/papers/32345613PubMed
635550144NOTCH-YAP1/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming Into Intrahepatic Cholangiocarcinoma.Gastroenterology2022https://conductscience.org/library/papers/35550144PubMed
733850002Small Molecule Inhibitors of TEAD Auto-palmitoylation Selectively Inhibit Proliferation and Tumor Growth of NF2-deficient Mesothelioma.Mol Cancer Ther2021https://conductscience.org/library/papers/33850002PubMed
836002248Epithelial SOX9 drives progression and metastases of gastric adenocarcinoma by promoting immunosuppressive tumour microenvironment.Gut2023https://conductscience.org/library/papers/36002248PubMed
939630608YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/STAT3 pathway and CXCL deregulation.J Clin Invest2024https://conductscience.org/library/papers/39630608PubMed
1024715453The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.Development2014https://conductscience.org/library/papers/24715453PubMed
1137419119Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression.Cancer Cell2023https://conductscience.org/library/papers/37419119PubMed
1239817679Cancer statistics, 2025.CA Cancer J Clin2025https://conductscience.org/library/papers/39817679PubMed
1329696628A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy.Int J Cancer2018https://conductscience.org/library/papers/29696628PubMed
1429665979Crosstalk between YAP/TAZ and Notch Signaling.Trends Cell Biol2018https://conductscience.org/library/papers/29665979PubMed
1534162421Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34162421PubMed
1629167315A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma.Mol Cancer Ther2018https://conductscience.org/library/papers/29167315PubMed
1738572751Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2024https://conductscience.org/library/papers/38572751PubMed
1837849539Novel Indazole Compounds as TEAD Inhibitors for Treating Cancer.ACS Med Chem Lett2023https://conductscience.org/library/papers/37849539PubMed
1936347846The Hippo signalling pathway and its implications in human health and diseases.Signal Transduct Target Ther2022https://conductscience.org/library/papers/36347846PubMed
2038443968Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy.J Exp Clin Cancer Res2024https://conductscience.org/library/papers/38443968PubMed

See all 37 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42131796Rewiring transcriptional plasticity: the case for dual YAP1 and TAZ targeting in gastric cancer peritoneal metastases.Cancer Heterog Plast2026https://conductscience.org/library/papers/42131796

Source PubMed

Download CSV of cited by

Genes26

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BIRC5332PubTator's text mininghttps://conductscience.org/library/genes/332NCBI Gene
CCN13491PubTator's text mininghttps://conductscience.org/library/genes/3491NCBI Gene
CCN21490PubTator's text mininghttps://conductscience.org/library/genes/1490NCBI Gene
CD1639332PubTator's text mininghttps://conductscience.org/library/genes/9332NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
EPCAM4072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
FOSB2354PubTator's text mininghttps://conductscience.org/library/genes/2354NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
JUN3725PubTator's text mininghttps://conductscience.org/library/genes/3725NCBI Gene
MRC14360PubTator's text mininghttps://conductscience.org/library/genes/4360NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene
SFN2810PubTator's text mininghttps://conductscience.org/library/genes/2810NCBI Gene
SNAI16615PubTator's text mininghttps://conductscience.org/library/genes/6615NCBI Gene
SOX96662PubTator's text mininghttps://conductscience.org/library/genes/6662NCBI Gene
SPATA29825PubTator's text mininghttps://conductscience.org/library/genes/9825NCBI Gene
TAFAZZIN6901PubTator's text mininghttps://conductscience.org/library/genes/6901NCBI Gene
TEAD17003PubTator's text mininghttps://conductscience.org/library/genes/7003NCBI Gene
TEAD28463PubTator's text mininghttps://conductscience.org/library/genes/8463NCBI Gene

See all 26 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42441024

GET https://conductscience.org/api/papers/v1/42441024/authors?page=2